Company intelligence
Kapadi
Research Services
Raleigh, US
201–500 employees
6 public signals
About Kapadi
Kapadi (former OncoBay, Clinscience and Exom) delivers specialized biotech Contract Research Organization (CRO) services, expertly navigating the intricacies of early-stage drug development. We harness state-of-the-art technology solutions and advanced data visualization to propel operational and data excellence. Our team's unwavering dedication to the field is evident, with each member bringing deep expertise in oncology, and pioneering areas like gene and cell therapy. At Kapadi, we're committed to accelerating the breakthroughs that will shape the future of cancer treatment.
Verified activity
Signals from Kapadi
6 published signals
People
Kapadi employee Stephanie Marques, SVP Clinical Solutions, joined fellow industry leaders at the SCDM Leadership Forum
Reported by Kapadi
Presence & Recognition
Kapadi is represented by Michael Surlak, Theodore Randall, and Scott E Smith, MD, PhD, FACP at the 7th CAR-T and Cell and Gene Therapy Summit from September 15 to 17.
Reported by Kapadi
Research & Knowledge
Kapadi published a webinar highlighting the results of the Phase III RASolute 302 study at ASCO 2026, where daraxonrasib reduced the risk of death by 60% compared with chemotherapy, extending median overall survival from 6.7 to 13.2 months and doubling progression-free survival.
Reported by Kapadi